Page 11234..1020..»

Category Archives: Ulcerative Colitis

Capital Digestive Care Taps 3 GIs for Maryland Locations – GlobeNewswire

Posted: November 25, 2019 at 10:48 am

November 22, 2019 06:02 ET | Source: Capital Digestive Care photo-release Drs. Stephen J. Park, Erica R. Continue reading

Posted in Ulcerative Colitis | Comments Off on Capital Digestive Care Taps 3 GIs for Maryland Locations – GlobeNewswire

Halifax doctor seeks poop samples in the name of research – CBC.ca

Posted: at 10:48 am

Dr. Tony Otley is using cheeky signs to draw attention to his new research Continue reading

Posted in Ulcerative Colitis | Comments Off on Halifax doctor seeks poop samples in the name of research – CBC.ca

When To Take Probiotics – The Best Time To Take Probiotics – Women’s Health

Posted: at 10:48 am

Probiotics are one of the biggest wellness trends of the moment. Not only can you find supplement versions, but everything from bottled water to tortilla chips are being laced with the friendly microbes. In case you need a refresher, probiotics are good bacteria thought to boost the health of your microbiome, or the balance of bacteria, fungi, and viruses that lives in your intestines Continue reading

Posted in Ulcerative Colitis | Comments Off on When To Take Probiotics – The Best Time To Take Probiotics – Women’s Health

What causes you to fart more than usual and the signs it’s something more serious – Mirror Online

Posted: at 10:48 am

Fart. Trump. Continue reading

Posted in Ulcerative Colitis | Comments Off on What causes you to fart more than usual and the signs it’s something more serious – Mirror Online

Rome suing over thirty companies in water pollution lawsuit – MDJOnline.com

Posted: at 10:48 am

Rome filed a civil lawsuit this week against over 30 companies that own or operate carpet-related facilities in Dalton. The lawsuit, filed Tuesday in Floyd County Superior Court, contends the companies including 3M, DuPont, Shaw Industries and others knew the perfluorinated compounds used in their manufacturing were toxic Continue reading

Posted in Ulcerative Colitis | Comments Off on Rome suing over thirty companies in water pollution lawsuit – MDJOnline.com

Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study Sites in its Phase 2b Ulcerative Colitis Clinical Trial and…

Posted: November 21, 2019 at 2:45 am

PARIS--(BUSINESS WIRE)--Regulatory News: ABIVAX SA (Euronext Paris: FR0012333284 ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, announced that the French National Regulatory Authority (ANSM) has approved the ABX464-103 Phase 2b study of its lead product candidate ABX464 with once a day convenient oral dosing for treatment of patients with moderate to severe active ulcerative colitis (UC). Prof. Continue reading

Posted in Ulcerative Colitis | Comments Off on Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study Sites in its Phase 2b Ulcerative Colitis Clinical Trial and…

Inflammatory Bowel Disease Insight Report: Current Therapies, Drug Pipeline and Outlook – BioSpace

Posted: at 2:45 am

Inflammatory bowel disease (IBD) is an umbrella term for two conditions, Crohns disease and ulcerative colitis, that are characterized by chronic inflammation of the gastrointestinal (GI) tract. This chronic and prolonged inflammation results in damage to the GI tract. Historically IBD has been predominantly seen in industrialized countries, with the highest reported prevalence values in Europe and North America. Continue reading

Posted in Ulcerative Colitis | Comments Off on Inflammatory Bowel Disease Insight Report: Current Therapies, Drug Pipeline and Outlook – BioSpace

Pfizers Xeljanz In the Crowded Rheumatoid Drugs Market – Forbes

Posted: at 2:45 am

Pfizer Inc. Continue reading

Posted in Ulcerative Colitis | Comments Off on Pfizers Xeljanz In the Crowded Rheumatoid Drugs Market – Forbes

Thetis Pharmaceuticals Receives Funding from the Crohn’s & Colitis Foundation to Support Investigational Mucosal Healing Therapy for Inflammatory…

Posted: at 2:45 am

Crohn's & Colitis Foundation's IBD Ventures award supports development of Thetis' novel first-in-class Resolvin oral therapy (TP-317) for treatment of ulcerative colitis and Crohn's disease BRANFORD, CT / ACCESSWIRE / November 19, 2019 / Thetis Pharmaceuticals ("Thetis"), a biopharmaceutical company developing novel therapies for gastrointestinal diseases, today announced receipt of funding from the Crohn's & Colitis Foundation's IBD Ventures program to support development of TP-317, a first-in-class, oral therapy for inflammatory bowel disease (IBD). The active agent in TP-317 is Resolvin E1, an endogenous immuno-resolvent first discovered by Dr. Continue reading

Posted in Ulcerative Colitis | Comments Off on Thetis Pharmaceuticals Receives Funding from the Crohn’s & Colitis Foundation to Support Investigational Mucosal Healing Therapy for Inflammatory…

Global Ulcerative Colitis Market by Types, Applications, Countries, Companies and Forecasts to 2024 covered in a Latest Research – Editorials 360

Posted: at 2:45 am

Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum) Continue reading

Posted in Ulcerative Colitis | Comments Off on Global Ulcerative Colitis Market by Types, Applications, Countries, Companies and Forecasts to 2024 covered in a Latest Research – Editorials 360

Page 11234..1020..»